应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XTLB Xtl生物制药
交易中 07-09 09:56:29 EDT
1.38
+0.15
+12.20%
最高
1.38
最低
1.35
成交量
5,707
今开
1.35
昨收
1.23
日振幅
2.44%
总市值
1,216万
流通市值
623.61万
总股本
881.39万
成交额
7,820
换手率
0.13%
流通股本
451.89万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Xtl生物制药7月8日成交额为1.54万美元
市场透视 · 08:13
Xtl生物制药7月8日成交额为1.54万美元
Xtl生物制药盘中异动 下午盘股价大涨5.30%
市场透视 · 07-07 17:25
Xtl生物制药盘中异动 下午盘股价大涨5.30%
Xtl生物制药7月3日成交额为5.64万美元
市场透视 · 07-04
Xtl生物制药7月3日成交额为5.64万美元
Xtl生物制药盘中异动 下午盘快速上涨7.23%
市场透视 · 07-02
Xtl生物制药盘中异动 下午盘快速上涨7.23%
Xtl生物制药6月30日成交额为5956.00美元
市场透视 · 07-01
Xtl生物制药6月30日成交额为5956.00美元
Xtl生物制药6月27日成交额为2008.00美元
市场透视 · 06-28
Xtl生物制药6月27日成交额为2008.00美元
Xtl生物制药盘中异动 早盘快速下跌5.01%报1.14美元
市场透视 · 06-26
Xtl生物制药盘中异动 早盘快速下跌5.01%报1.14美元
Xtl生物制药盘中异动 股价大跌7.63%报1.21美元
市场透视 · 06-25
Xtl生物制药盘中异动 股价大跌7.63%报1.21美元
Xtl生物制药盘中异动 股价大涨8.82%
市场透视 · 06-24
Xtl生物制药盘中异动 股价大涨8.82%
Xtl生物制药股价拉升20.98% 市值涨212.63万美元
市场透视 · 06-23
Xtl生物制药股价拉升20.98% 市值涨212.63万美元
Xtl生物制药盘中异动 大幅下挫5.78%报1.15美元
市场透视 · 06-20
Xtl生物制药盘中异动 大幅下挫5.78%报1.15美元
Xtl生物制药盘中异动 股价大涨7.14%
市场透视 · 06-16
Xtl生物制药盘中异动 股价大涨7.14%
Xtl生物制药盘中异动 快速下挫12.50%
市场透视 · 06-13
Xtl生物制药盘中异动 快速下挫12.50%
Xtl生物制药盘中异动 急速拉升7.73%
市场透视 · 06-09
Xtl生物制药盘中异动 急速拉升7.73%
Xtl生物制药盘中异动 股价大跌9.22%报1.05美元
市场透视 · 06-06
Xtl生物制药盘中异动 股价大跌9.22%报1.05美元
Xtl生物制药盘中异动 急速下挫6.66%报1.12美元
市场透视 · 06-04
Xtl生物制药盘中异动 急速下挫6.66%报1.12美元
Xtl生物制药盘中异动 急速拉升7.76%报1.25美元
市场透视 · 05-30
Xtl生物制药盘中异动 急速拉升7.76%报1.25美元
Xtl生物制药盘中异动 早盘股价大涨10.14%
市场透视 · 05-27
Xtl生物制药盘中异动 早盘股价大涨10.14%
Xtl生物制药盘中异动 股价大跌5.40%报1.05美元
市场透视 · 05-19
Xtl生物制药盘中异动 股价大跌5.40%报1.05美元
Xtl生物制药盘中异动 快速跳水6.14%
市场透视 · 05-16
Xtl生物制药盘中异动 快速跳水6.14%
加载更多
公司概况
公司名称:
Xtl生物制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Xtl Biopharmaceuticals Ltd.在以色列国法律下于1993年3月9日依法成立。公司从事于药物产品的收购和研发,为了满足未得到满足的医疗需求。最近在致力于MM的治疗,精神分裂症和丙型肝炎。公司研究、研发和出售通过处理器治疗的非药用和非侵入性治疗多种疾病的家庭治疗设备。治疗的疾病例如有高血压、心力衰竭、失眠和精神紧张。
发行价格:
--
{"stockData":{"symbol":"XTLB","market":"US","secType":"STK","nameCN":"Xtl生物制药","latestPrice":1.38,"timestamp":1752068791847,"preClose":1.23,"halted":0,"volume":5707,"delay":0,"floatShares":4518888,"shares":8813851,"eps":-0.2999,"marketStatus":"交易中","change":0.15,"latestTime":"07-09 09:56:29 EDT","open":1.35,"high":1.38,"low":1.35,"amount":7820.4322196,"amplitude":0.02439,"askPrice":1.38,"askSize":2,"bidPrice":1.33,"bidSize":341,"shortable":3,"etf":0,"ttmEps":-0.2999,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752091200000},"marketStatusCode":2,"adr":0,"adrRate":100,"exchange":"NASDAQ","adjPreClose":1.23,"preHourTrading":{"tag":"盘前","latestPrice":1.32,"preClose":1.23,"latestTime":"09:29 EDT","volume":2204,"amount":2932.2798420000004,"timestamp":1752067770067},"postHourTrading":{"tag":"盘后","latestPrice":1.23,"preClose":1.23,"latestTime":"18:11 EDT","volume":1,"amount":1.23,"timestamp":1752012675120},"volumeRatio":3.912037},"requestUrl":"/m/hq/s/XTLB","defaultTab":"news","newsList":[{"id":"2550992682","title":"Xtl生物制药7月8日成交额为1.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550992682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550992682?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:13","pubTimestamp":1752048835,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日,Xtl生物制药成交额为1.54万美元,成交额较昨日减少16.16%,当日成交量为1.22万股。Xtl生物制药于2025年7月8日涨0.82%,报1.23美元,该股过去5个交易日涨7.89%,年初至今跌39.41%,过去60日涨5.13%。其产品包括hCDR1和重组人促红细胞生成素。hCDR1 是一种合成肽,包含大约 20 个氨基酸残基。rHuEPO 是一种已知的贫血药物,正在开发中以延长晚期多发性骨髓瘤 患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709164735a69f013c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709164735a69f013c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2549517005","title":"Xtl生物制药盘中异动 下午盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549517005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549517005?lang=zh_cn&edition=full","pubTime":"2025-07-08 01:25","pubTimestamp":1751909155,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日01时25分,Xtl生物制药股票出现异动,股价急速上涨5.30%。截至发稿,该股报1.39美元/股,成交量5672股,换手率0.06%,振幅5.52%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体跌幅为0.61%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708012555979d4765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708012555979d4765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2548394377","title":"Xtl生物制药7月3日成交额为5.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548394377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548394377?lang=zh_cn&edition=full","pubTime":"2025-07-04 15:46","pubTimestamp":1751615172,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日,Xtl生物制药成交额为5.64万美元,成交额较昨日增加40.92%,当日成交量为4.38万股。Xtl生物制药于2025年7月3日涨10.0%,报1.32美元,该股过去5个交易日涨11.86%,年初至今跌34.98%,过去60日涨16.81%。其产品包括hCDR1和重组人促红细胞生成素。hCDR1 是一种合成肽,包含大约 20 个氨基酸残基。rHuEPO 是一种已知的贫血药物,正在开发中以延长晚期多发性骨髓瘤 患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704160524a72e570a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704160524a72e570a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2548781469","title":"Xtl生物制药盘中异动 下午盘快速上涨7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548781469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548781469?lang=zh_cn&edition=full","pubTime":"2025-07-03 01:40","pubTimestamp":1751478050,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日01时40分,Xtl生物制药股票出现异动,股价急速上涨7.23%。截至发稿,该股报1.26美元/股,成交量2469股,换手率0.03%,振幅5.11%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.99%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070301405097978d01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070301405097978d01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2548071100","title":"Xtl生物制药6月30日成交额为5956.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548071100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548071100?lang=zh_cn&edition=full","pubTime":"2025-07-01 15:35","pubTimestamp":1751355323,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日,Xtl生物制药成交额为5956.00美元,成交额较昨日增加196.61%,当日成交量为5200.00股。Xtl生物制药于2025年6月30日跌1.72%,报1.14美元,该股过去5个交易日涨11.76%,年初至今跌43.84%,过去60日跌8.06%。其产品包括hCDR1和重组人促红细胞生成素。hCDR1 是一种合成肽,包含大约 20 个氨基酸残基。rHuEPO 是一种已知的贫血药物,正在开发中以延长晚期多发性骨髓瘤 患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701162129a727f639&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701162129a727f639&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2546771775","title":"Xtl生物制药6月27日成交额为2008.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546771775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546771775?lang=zh_cn&edition=full","pubTime":"2025-06-28 15:20","pubTimestamp":1751095257,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日,Xtl生物制药成交额为2008.00美元,成交额较昨日减少90.78%,当日成交量为1711.00股。Xtl生物制药于2025年6月27日跌1.82%,报1.16美元,该股过去5个交易日涨21.98%,年初至今跌42.86%,过去60日跌0.85%。hCDR1 是一种合成肽,包含大约 20 个氨基酸残基。rHuEPO 是一种已知的贫血药物,正在开发中以延长晚期多发性骨髓瘤 患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628152105a4c2a053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628152105a4c2a053&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2546732383","title":"Xtl生物制药盘中异动 早盘快速下跌5.01%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546732383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546732383?lang=zh_cn&edition=full","pubTime":"2025-06-26 22:47","pubTimestamp":1750949270,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日22时47分,Xtl生物制药股票出现异动,股价快速跳水5.01%。截至发稿,该股报1.14美元/股,成交量847股,换手率0.01%,振幅2.92%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.08%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626224750a71f147b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626224750a71f147b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2546450142","title":"Xtl生物制药盘中异动 股价大跌7.63%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546450142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546450142?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:37","pubTimestamp":1750858621,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时37分,Xtl生物制药股票出现异动,股价急速下跌7.63%。截至发稿,该股报1.21美元/股,成交量8950股,换手率0.10%,振幅0.38%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体跌幅为0.54%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213701a4bd71cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625213701a4bd71cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2545623837","title":"Xtl生物制药盘中异动 股价大涨8.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545623837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545623837?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:31","pubTimestamp":1750771918,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时31分,Xtl生物制药股票出现波动,股价快速上涨8.82%。截至发稿,该股报1.11美元/股,成交量1.0193万股,换手率0.12%,振幅0.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.60%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213158a4bb95e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213158a4bb95e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2545410050","title":"Xtl生物制药股价拉升20.98% 市值涨212.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545410050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545410050?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:31","pubTimestamp":1750685510,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时31分,Xtl生物制药股票出现异动,股价快速拉升20.98%。截至发稿,该股报1.150美元/股,成交量2477股,换手率0.03%,振幅0.01%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.30%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213150a4b92396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213150a4b92396&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2544761541","title":"Xtl生物制药盘中异动 大幅下挫5.78%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544761541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544761541?lang=zh_cn&edition=full","pubTime":"2025-06-20 23:09","pubTimestamp":1750432189,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日23时09分,Xtl生物制药股票出现异动,股价大幅下跌5.78%。截至发稿,该股报1.15美元/股,成交量2243股,换手率0.03%,振幅7.37%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体跌幅为0.82%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506202309499788200a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506202309499788200a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2543605745","title":"Xtl生物制药盘中异动 股价大涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543605745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543605745?lang=zh_cn&edition=full","pubTime":"2025-06-16 22:19","pubTimestamp":1750083572,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日22时19分,Xtl生物制药股票出现异动,股价急速上涨7.14%。截至发稿,该股报1.20美元/股,成交量1927股,换手率0.02%,振幅3.57%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体跌幅为0.16%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616221932a4ac4886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616221932a4ac4886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2543633630","title":"Xtl生物制药盘中异动 快速下挫12.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543633630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543633630?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:23","pubTimestamp":1749824626,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时23分,Xtl生物制药股票出现波动,股价快速跳水12.50%。截至发稿,该股报1.05美元/股,成交量151股,换手率0.00%,振幅0.00%。Xtl生物制药股票所在的生物技术行业中,整体跌幅为0.58%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物,正在开发中以延长晚期多发性骨髓瘤 患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613222347951b32ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613222347951b32ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2542338167","title":"Xtl生物制药盘中异动 急速拉升7.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542338167?lang=zh_cn&edition=full","pubTime":"2025-06-09 22:10","pubTimestamp":1749478202,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日22时10分,Xtl生物制药股票出现异动,股价急速拉升7.73%。截至发稿,该股报1.19美元/股,成交量735股,换手率0.01%,振幅0.00%。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.48%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物,正在开发中以延长晚期多发性骨髓瘤 患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609221002a700ba6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609221002a700ba6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2541866216","title":"Xtl生物制药盘中异动 股价大跌9.22%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541866216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541866216?lang=zh_cn&edition=full","pubTime":"2025-06-06 22:22","pubTimestamp":1749219723,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时22分,Xtl生物制药股票出现波动,股价大幅跳水9.22%。截至发稿,该股报1.05美元/股,成交量896股,换手率0.01%,振幅0.00%。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.59%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。hCDR1 是一种合成肽,包含大约 20 个氨基酸残基。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606222203a6fd55a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606222203a6fd55a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2540062666","title":"Xtl生物制药盘中异动 急速下挫6.66%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540062666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540062666?lang=zh_cn&edition=full","pubTime":"2025-06-04 22:39","pubTimestamp":1749047969,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日22时39分,Xtl生物制药股票出现异动,股价急速跳水6.66%。截至发稿,该股报1.12美元/股,成交量433股,换手率0.00%,振幅1.64%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.62%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060422393097719e6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060422393097719e6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2539710002","title":"Xtl生物制药盘中异动 急速拉升7.76%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539710002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539710002?lang=zh_cn&edition=full","pubTime":"2025-05-31 01:19","pubTimestamp":1748625558,"startTime":"0","endTime":"0","summary":"北京时间2025年05月31日01时19分,Xtl生物制药股票出现波动,股价急速上涨7.76%。截至发稿,该股报1.25美元/股,成交量2903股,换手率0.03%,振幅0.86%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体跌幅为4.13%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531011919976b6a76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531011919976b6a76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2538462330","title":"Xtl生物制药盘中异动 早盘股价大涨10.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538462330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538462330?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:34","pubTimestamp":1748352884,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时34分,Xtl生物制药股票出现异动,股价大幅上涨10.14%。截至发稿,该股报1.22美元/股,成交量2109股,换手率0.02%,振幅11.71%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.60%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213444a48e74a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213444a48e74a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2536321966","title":"Xtl生物制药盘中异动 股价大跌5.40%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536321966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536321966?lang=zh_cn&edition=full","pubTime":"2025-05-20 03:19","pubTimestamp":1747682340,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日03时19分,Xtl生物制药股票出现异动,股价快速下挫5.40%。截至发稿,该股报1.05美元/股,成交量6681股,换手率0.08%,振幅7.21%。Xtl生物制药股票所在的生物技术行业中,整体涨幅为0.40%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520031901aa2c9335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520031901aa2c9335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2535313048","title":"Xtl生物制药盘中异动 快速跳水6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535313048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535313048?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:45","pubTimestamp":1747403102,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时45分,Xtl生物制药股票出现异动,股价急速跳水6.14%。截至发稿,该股报1.07美元/股,成交量1449股,换手率0.02%,振幅0.00%。Xtl生物制药股票所在的生物技术行业中,整体跌幅为0.07%。Xtl生物制药公司简介:XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物,正在开发中以延长晚期多发性骨髓瘤 患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血,包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214502a6e1bc83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214502a6e1bc83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xtlbio.com","stockEarnings":[{"period":"1week","weight":0.0468},{"period":"1month","weight":0.1182},{"period":"3month","weight":0.0513},{"period":"6month","weight":-0.385},{"period":"1year","weight":-0.4652},{"period":"ytd","weight":-0.3928}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xtl Biopharmaceuticals Ltd.在以色列国法律下于1993年3月9日依法成立。公司从事于药物产品的收购和研发,为了满足未得到满足的医疗需求。最近在致力于MM的治疗,精神分裂症和丙型肝炎。公司研究、研发和出售通过处理器治疗的非药用和非侵入性治疗多种疾病的家庭治疗设备。治疗的疾病例如有高血压、心力衰竭、失眠和精神紧张。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.099791},{"month":2,"riseRate":0.375,"avgChangeRate":-0.035412},{"month":3,"riseRate":0.375,"avgChangeRate":0.154077},{"month":4,"riseRate":0.4375,"avgChangeRate":-0.01928},{"month":5,"riseRate":0.266667,"avgChangeRate":-0.059048},{"month":6,"riseRate":0.466667,"avgChangeRate":0.000234},{"month":7,"riseRate":0.4375,"avgChangeRate":0.460306},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.032037},{"month":9,"riseRate":0.2,"avgChangeRate":-0.078439},{"month":10,"riseRate":0.375,"avgChangeRate":-0.021569},{"month":11,"riseRate":0.375,"avgChangeRate":-0.052873},{"month":12,"riseRate":0.25,"avgChangeRate":-0.050068}],"exchange":"NASDAQ","name":"Xtl生物制药","nameEN":"XTL Biopharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xtl生物制药,XTLB,Xtl生物制药股票,Xtl生物制药股票老虎,Xtl生物制药股票老虎国际,Xtl生物制药行情,Xtl生物制药股票行情,Xtl生物制药股价,Xtl生物制药股市,Xtl生物制药股票价格,Xtl生物制药股票交易,Xtl生物制药股票购买,Xtl生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}